ケンタッキー州における2型糖尿病の臨床試験
ケンタッキー州内の拠点で、2型糖尿病に関する12件の研究が参加者を募集しています。
ケンタッキー州内の都市
公式研究テキスト（英語）
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- AMR Lexington, Lexington
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Qualmedica Research - Bowling Green, Bowling Green
- The Research Group of Lexington, Lexington
- Research Integrity, LLC, Owensboro
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07064473A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- St Elizabeth Health Care - CRI, Edgewood
- UofL Health, Louisville
被験者募集中健康なボランティア歓迎
55歳以上 · 全性別 · 2026/09/28更新 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Monroe Biomedical Research, Louisville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Bowling Green
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07662213Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- St. Elizabeth Healthcare, Edgewood
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07296484AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- The Research Group of Lexington LLC, Lexington
被験者募集中第3相
45歳以上 · 全性別 · 2026/09/01更新 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Lexington
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/31更新 · NCT07662044A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Norton Children's Endocrinology, Louisville
被験者募集中第3相
10歳〜17歳 · 全性別 · 2026/08/07更新 · NCT06739122Time-restricted Eating for Patients With Type 2 Diabetes
- University of Kentucky Barnstable Brown Diabetes Center, Lexington
被験者募集中
18歳以上 · 全性別 · 2026/07/31更新 · NCT07318207OASIS: Peer Support for T2DM in Appalachia (Peer Participant)
- Barren River Area Development District, Bowling Green
- UK HealthCare, Hazard
被験者募集中
55歳以上 · 全性別 · 2026/06/17更新 · NCT06336122OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)
- Barren River Area Development District, Bowling Green
- UK HealthCare, Hazard
被験者募集中
55歳以上 · 全性別 · 2026/06/17更新 · NCT06003634ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。